Senior insider sale
Chief Financial Officer at XERIS BIOPHARMA HOLDINGS, INC. — senior position signals high conviction
$144.1K
17.40K shares
What this filing means
PIEPER STEVEN plans to sell 17.40K shares of XERIS BIOPHARMA HOLDINGS, INC. valued at approximately $144.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/6/2026ACC: 0001950047-26-006884
Officer· Chief Financial Officer
Since Oct 2021
17.40K
Shares to sell
$144.1K
Approx. market value
17.40K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Restricted Stock Units
N/A
12/28/2017
17KOpen Market Purchase
Cash
5/17/2017
400.00Total acquired17.40K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/28/2017 | Restricted Stock Units N/A | 17K | — |
5/17/2017 | Open Market Purchase Cash | 400.00 | — |
| Total | 17.40K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
17.40K
Market value
$144.1K
7/6/2026
Total
Units
17.40K
Value
$144.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/6/2026 | 17.40K | $144.1K | NASDAQ | Planned |
| Total | 17.40K | $144.1K | ||